Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer

Status Completed

Clinical Trial Summary

The goal of this observational study is to identify predictive factors and to develop a risk model predicting para-aortic lymph node metastasis in patients with locally advanced cervical cancer based on the analysis of surgical staging results. The main questions it aims to answer are: - What are the risk factors to predict para-aortic lymph node metastasis in patients with locally advanced cervical cancer? - What is the indication for prophylactic extended-field radiation therapy in patients with locally advanced cervical cancer Individual data of patients with locally advanced cervical cancer treated with surgical staging at our institution from 2020 to 2022 were pooled analysed.Multivariate Logistic regression analysis was used to identify the predictive factors and to develop the prediction model.

Clinical Trial Description

Individual data of 336 patients with locally advanced cervical cancer treated with surgical staging at our institution from January 2020 to August 2022 were pooled analysed. The following factors were collected from each patient to identify variables predicting para-aortic lymph node metastasis: age, T-staging，histopathological type，tumor size, differentiation, pretreatment tumor markers (squamous carcinoma antigen, carcinoembryonic antigen, Carbohydrate antigen 125 and cytokeratin fragment 21-1 , human papilloma virus type, the status of pelvic lymph node on images, common iliac lymph node and the short-axis diameter of the largest positive and the status of para-aortic lymph node on surgical staging results. Multivariate Logistic regression analysis was used to develop the prediction model. A simplified scoring system for each independent predictive factors was developed according to its coefficient. Internal validation was performed to assess the model. An independent validation cohort contained 116 patients with the same criteria from March 2018 to December 2019. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05717751
Study type	Observational
Source	Chongqing University Cancer Hospital
Contact
Status	Completed
Phase
Start date	April 13, 2022
Completion date	December 12, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03225443` - Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy	N/A
Recruiting	`NCT06079671` - Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)	Phase 3
Completed	`NCT05059119` - Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients
Recruiting	`NCT06055738` - Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC	Phase 2
Recruiting	`NCT06156514` - Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer	Phase 3
Completed	`NCT03298893` - Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months	Phase 1/Phase 2
Withdrawn	`NCT01514955` - An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer	Phase 1
Recruiting	`NCT05950087` - Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
Recruiting	`NCT04884906` - Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer	Phase 2
Not yet recruiting	`NCT05799469` - Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer	Phase 2
Recruiting	`NCT05311566` - PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer	Phase 2
Terminated	`NCT02045433` - Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer	Phase 2
Recruiting	`NCT06237257` - A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer	Phase 2
Not yet recruiting	`NCT06288373` - Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC	Phase 2/Phase 3
Not yet recruiting	`NCT06288360` - Neoadjuvant Immunochemotherapy in PD-L1-negative LACC	Phase 2
Recruiting	`NCT06068387` - A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis	N/A
Recruiting	`NCT05378087` - Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer	N/A
Recruiting	`NCT03963882` - NAC Followed by RH for the Treatment of LACC	Phase 2
Recruiting	`NCT01938105` - Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer	Phase 2
Active, not recruiting	`NCT01793701` - Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer	Phase 1/Phase 2